Key facts
- The Nikkei 225 index will reduce Advantest's weighting.
- The change will be effective from October 1.
- Advantest's share price caused its weighting to exceed the 10% index share limit.
- A cap is applied to prevent single stocks from becoming overly dominant in the index.
The Nikkei 225 index will implement a reduction in the weighting of Advantest, a prominent manufacturer of semiconductor testing equipment. This adjustment is scheduled to take effect on October 1. The decision stems from Advantest's significant share price increase, which has resulted in its weighting within the index surpassing the established 10% cap. This cap is a standard mechanism designed to prevent any single constituent stock from becoming disproportionately dominant in the index. By applying this cap, the Nikkei aims to maintain a more balanced representation of the market and mitigate the impact of any one company's performance on the overall index value. The move ensures that the Nikkei 225 remains a more diversified benchmark for the Japanese stock market.